💊 Akagera Medicines joins CEPI’s 100 Days Mission; Europe’s strategy for AI in medicines regulation; EU countries dump hoarded vaccines

#497 | A new “variant of interest”; The end of COVAX; A new South-South health cooperation initiative

Hello, and welcome back to The Kable. Yesterday, the WHO classified the JN.1 coronavirus strain as a "variant of interest". Current evidence suggests that the risk to public health from this strain is low. While it is more easily transmissible than currently circulating strains, it does not cause more severe disease. 

While we're on the topic of Covid, 3…